by Beth Cullen | Feb 28, 2022 | Education
Rare Disease Day is the globally-coordinated movement on rare diseases, working towards equity in social opportunity, healthcare, and access to diagnosis and therapies for people living with a rare disease. Control Bionics is proud to help people all over the world...
by Beth Cullen | Feb 17, 2022 | Education, Investor Relations
According to the recent paper published by biomedical engineering student Lester Lo at RMIT University, eye gaze combined with EMG switching outperformed traditional eye gaze AAC systems. The study was designed to test the speed and accuracy of an eye gaze...
by Beth Cullen | Feb 16, 2022 | Education
At AITA 2022, Control Bionics showed the new Cosmos Connect device connected to the NeuroNode Trilogy. The Cosmos Connect is a small, portable device that turns a single NeuroNode sensor into multiple outputs. The device allows up to 8 wired outputs and one Bluetooth...
by Beth Cullen | Feb 2, 2022 | Investor Relations
Featured in a writeup by Kalkine Media, Control Bionics is proud to report a 34% sales revenue growth in the December quarter. The article highlighted Control Bionics’ strong sales in the US market, robust pipeline in Australia, two new product launches, and a...
by Beth Cullen | Jan 4, 2022 | User Stories
Ian is an energetic 4 year old interested in toys, snacks, and his older brother. Ian was born with Cytomegalovirus (CMV), but his father wasn’t worried. Ian’s parents are both speech language pathologists and “everything we’d done in our lives...
